118 related articles for article (PubMed ID: 30598492)
1. Novel insights into the role of aberrantly expressed MNX1 (HLXB9) in infant acute myeloid leukemia.
Schwaller J
Haematologica; 2019 Jan; 104(1):1-3. PubMed ID: 30598492
[No Abstract] [Full Text] [Related]
2. The homeobox transcription factor HB9 induces senescence and blocks differentiation in hematopoietic stem and progenitor cells.
Ingenhag D; Reister S; Auer F; Bhatia S; Wildenhain S; Picard D; Remke M; Hoell JI; Kloetgen A; Sohn D; Jänicke RU; Koegler G; Borkhardt A; Hauer J
Haematologica; 2019 Jan; 104(1):35-46. PubMed ID: 30093397
[TBL] [Abstract][Full Text] [Related]
3. Quantification of EVI1 transcript levels in acute myeloid leukemia by RT-qPCR analysis: A study by the ALFA Group.
Smol T; Nibourel O; Marceau-Renaut A; Celli-Lebras K; Berthon C; Quesnel B; Boissel N; Terré C; Thomas X; Castaigne S; Dombret H; Preudhomme C; Renneville A
Leuk Res; 2015 Dec; 39(12):1443-7. PubMed ID: 26467814
[TBL] [Abstract][Full Text] [Related]
4. Modulation of homeobox B6 and B9 genes expression in human leukemia cell lines during myelomonocytic differentiation.
Ohnishi K; Tobita T; Sinjo K; Takeshita A; Ohno R
Leuk Lymphoma; 1998 Nov; 31(5-6):599-608. PubMed ID: 9922051
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of miR‑135a predicts poor prognosis in acute myeloid leukemia and regulates leukemia progression via modulating HOXA10 expression.
Xu H; Wen Q
Mol Med Rep; 2018 Jul; 18(1):1134-1140. PubMed ID: 29845297
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell-cell interacting genes distinguishes HLXB9/TEL from MLL-positive childhood acute myeloid leukemia.
Wildenhain S; Ruckert C; Röttgers S; Harbott J; Ludwig WD; Schuster FR; Beldjord K; Binder V; Slany R; Hauer J; Borkhardt A
Leukemia; 2010 Sep; 24(9):1657-60. PubMed ID: 20596032
[No Abstract] [Full Text] [Related]
7. Aberrant activity of NKL homeobox gene NKX3-2 in a T-ALL subset.
Nagel S; Meyer C; Kaufmann M; Zaborski M; MacLeod RAF; Drexler HG
PLoS One; 2018; 13(5):e0197194. PubMed ID: 29746601
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia.
Sadras T; Perugini M; Kok CH; Iarossi DG; Heatley SL; Brumatti G; Samuel MS; To LB; Lewis ID; Lopez AF; Ekert PG; Ramshaw HS; D'Andrea RJ
J Leukoc Biol; 2014 Jul; 96(1):83-91. PubMed ID: 24598054
[TBL] [Abstract][Full Text] [Related]
9. The dual role of HLXB9 in leukemia.
Ferguson S; Gautrey HE; Strathdee G
Pediatr Blood Cancer; 2011 Mar; 56(3):349-52. PubMed ID: 21069786
[TBL] [Abstract][Full Text] [Related]
10. Homeobox protein HB9 binds to the prostaglandin E receptor 2 promoter and inhibits intracellular cAMP mobilization in leukemic cells.
Wildenhain S; Ingenhag D; Ruckert C; Degistirici Ö; Dugas M; Meisel R; Hauer J; Borkhardt A
J Biol Chem; 2012 Nov; 287(48):40703-12. PubMed ID: 23048027
[TBL] [Abstract][Full Text] [Related]
11. The vent-like homeobox gene VENTX promotes human myeloid differentiation and is highly expressed in acute myeloid leukemia.
Rawat VP; Arseni N; Ahmed F; Mulaw MA; Thoene S; Heilmeier B; Sadlon T; D'Andrea RJ; Hiddemann W; Bohlander SK; Buske C; Feuring-Buske M
Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16946-51. PubMed ID: 20833819
[TBL] [Abstract][Full Text] [Related]
12. MNX1-ETV6 fusion gene in an acute megakaryoblastic leukemia and expression of the MNX1 gene in leukemia and normal B cell lines.
Taketani T; Taki T; Sako M; Ishii T; Yamaguchi S; Hayashi Y
Cancer Genet Cytogenet; 2008 Oct; 186(2):115-9. PubMed ID: 18940475
[TBL] [Abstract][Full Text] [Related]
13. 4q12 translocations with GSX2 expression identify a CD7(+) acute myeloid leukaemia subset.
Di Giacomo D; La Starza R; Barba G; Pierini V; Baldazzi C; Storlazzi CT; Daniele G; Forghieri F; Borlenghi E; Testoni N; Mecucci C
Br J Haematol; 2015 Oct; 171(1):141-5. PubMed ID: 25816740
[No Abstract] [Full Text] [Related]
14. Three-way complex translocations in infant acute myeloid leukemia with t(7;12)(q36;p13): the incidence and correlation of a HLXB9 overexpression.
Park J; Kim M; Lim J; Kim Y; Han K; Lee J; Chung NG; Cho B; Kim HK
Cancer Genet Cytogenet; 2009 Jun; 191(2):102-5. PubMed ID: 19446746
[TBL] [Abstract][Full Text] [Related]
15. Widespread over-expression of the non-clustered homeobox gene HLX in acute myeloid leukemia.
Fröhling S
Haematologica; 2012 Oct; 97(10):1453. PubMed ID: 23053668
[No Abstract] [Full Text] [Related]
16. HoxA10 activates CDX4 transcription and Cdx4 activates HOXA10 transcription in myeloid cells.
Bei L; Huang W; Wang H; Shah C; Horvath E; Eklund E
J Biol Chem; 2011 May; 286(21):19047-64. PubMed ID: 21471217
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia and the Wnt pathway.
Eaves CJ; Humphries RK
N Engl J Med; 2010 Jun; 362(24):2326-7. PubMed ID: 20554989
[No Abstract] [Full Text] [Related]
18. Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression.
Ding X; Yang Z; Zhou F; Wang F; Li X; Chen C; Li X; Hu X; Xiang S; Zhang J
Int J Biochem Cell Biol; 2013 Aug; 45(8):1647-56. PubMed ID: 23660297
[TBL] [Abstract][Full Text] [Related]
19. Linkage of Meis1 leukemogenic activity to multiple downstream effectors including Trib2 and Ccl3.
Argiropoulos B; Palmqvist L; Yung E; Kuchenbauer F; Heuser M; Sly LM; Wan A; Krystal G; Humphries RK
Exp Hematol; 2008 Jul; 36(7):845-59. PubMed ID: 18375036
[TBL] [Abstract][Full Text] [Related]
20. The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML.
Zangenberg M; Grubach L; Aggerholm A; Silkjaer T; Juhl-Christensen C; Nyvold CG; Kjeldsen E; Ommen HB; Hokland P
Eur J Haematol; 2009 Nov; 83(5):439-48. PubMed ID: 19563517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
